Literature DB >> 17351618

A structural basis for complement inhibition by Staphylococcus aureus.

Michal Hammel1, Georgia Sfyroera, Daniel Ricklin, Paola Magotti, John D Lambris, Brian V Geisbrecht.   

Abstract

To provide insight into bacterial suppression of complement-mediated immunity, we present here structures of a bacterial complement inhibitory protein, both free and bound to its complement target. The 1.25-A structure of the complement component C3-inhibitory domain of Staphylococcus aureus extracellular fibrinogen-binding protein (Efb-C) demonstrated a helical motif involved in complement regulation, whereas the 2.2-A structure of Efb-C bound to the C3d domain of human C3 allowed insight into the recognition of complement proteins by invading pathogens. Our structure-function studies provided evidence for a previously unrecognized mode of complement inhibition whereby Efb-C binds to native C3 and alters the solution conformation of C3 in a way that renders it unable to participate in successful 'downstream' activation of the complement response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351618     DOI: 10.1038/ni1450

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  83 in total

1.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

2.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

3.  A structure-based benchmark for protein-protein binding affinity.

Authors:  Panagiotis L Kastritis; Iain H Moal; Howook Hwang; Zhiping Weng; Paul A Bates; Alexandre M J J Bonvin; Joël Janin
Journal:  Protein Sci       Date:  2011-02-16       Impact factor: 6.725

4.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

5.  Allosteric inhibition of complement function by a staphylococcal immune evasion protein.

Authors:  Hui Chen; Daniel Ricklin; Michal Hammel; Brandon L Garcia; William J McWhorter; Georgia Sfyroera; You-Qiang Wu; Apostolia Tzekou; Sheng Li; Brian V Geisbrecht; Virgil L Woods; John D Lambris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

Review 6.  Complement-targeted therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Nat Biotechnol       Date:  2007-11       Impact factor: 54.908

7.  The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution.

Authors:  Michal Hammel; Daniel Nemecek; J Andrew Keightley; George J Thomas; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

8.  SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis.

Authors:  Tyler K Nygaard; Kyler B Pallister; Peter Ruzevich; Shannon Griffith; Cuong Vuong; Jovanka M Voyich
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

9.  Dynamic structural changes during complement C3 activation analyzed by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael C Schuster; Daniel Ricklin; Krisztián Papp; Kathleen S Molnar; Stephen J Coales; Yoshitomo Hamuro; Georgia Sfyroera; Hui Chen; Michael S Winters; John D Lambris
Journal:  Mol Immunol       Date:  2008-05-05       Impact factor: 4.407

10.  Native State of Complement Protein C3d Analysed via Hydrogen Exchange and Conformational Sampling.

Authors:  Didier Devaurs; Malvina Papanastasiou; Dinler A Antunes; Jayvee R Abella; Mark Moll; Daniel Ricklin; John D Lambris; Lydia E Kavraki
Journal:  Int J Comput Biol Drug Des       Date:  2018-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.